Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The GABAergic system in Alzheimer’s disease: a systematic review with meta-analysis
Giovanna Carello‐Collar, Bruna Bellaver, Pâmela C.L. Ferreira, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 12, pp. 5025-5036
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 219
Implications of microbe-derived ɣ-aminobutyric acid (GABA) in gut and brain barrier integrity and GABAergic signaling in Alzheimer’s disease
Kathryn A Conn, Emily M. Borsom, Emily K. Cope
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 14
A paradoxical switch: the implications of excitatory GABAergic signaling in neurological disorders
Colin J. McArdle, Alana A. Arnone, Chelcie F. Heaney, et al.
Frontiers in Psychiatry (2024) Vol. 14
Open Access | Times Cited: 10
Impairments of GABAergic transmission in hippocampus mediate increased susceptibility of epilepsy in the early stage of Alzheimer’s disease
Rui Mao, Mengsha Hu, Xuan Liu, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 9
CEST imaging combined with 1H-MRS reveal the neuroprotective effects of riluzole by improving neurotransmitter imbalances in Alzheimer’s disease mice
Yuanyu Shen, Xiaolei Zhang, Si-qi Liu, et al.
Alzheimer s Research & Therapy (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 1
CRISPR-based epigenetic editing of Gad1 improves synaptic inhibition and cognitive behavior in a Tauopathy mouse model
Lei Wan, Ping Zhong, Pei Li, et al.
Neurobiology of Disease (2025) Vol. 206, pp. 106826-106826
Open Access | Times Cited: 1
Therapeutic Role of Heterocyclic Compounds in Neurodegenerative Diseases: Insights from Alzheimer’s and Parkinson’s Diseases
Nidhi Puranik, Minseok Song
Neurology International (2025) Vol. 17, Iss. 2, pp. 26-26
Open Access | Times Cited: 1
Heterogeneous brain abnormalities in subjective cognitive decline converge on a common network and their transcriptional signature
Huan Lan, Wei Liu, Chao Zuo, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access | Times Cited: 1
Milestone review: GABA, from chemistry, conformations, ionotropic receptors, modulators, epilepsy, flavonoids, and stress to neuro‐nutraceuticals
Graham A.R. Johnston, Philip M. Beart
Journal of Neurochemistry (2024) Vol. 168, Iss. 7, pp. 1179-1192
Open Access | Times Cited: 5
Alzheimer’s Disease and Epilepsy: Exploring Shared Pathways and Promising Biomarkers for Future Treatments
Athanasios-Christos Kalyvas, Maria Dimitriou, Panagiotis Ioannidis, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 13, pp. 3879-3879
Open Access | Times Cited: 5
Quantification and correlation of amyloid-β plaque load, glial activation, GABAergic interneuron numbers, and cognitive decline in the young TgF344-AD rat model of Alzheimer’s disease
Anett Futácsi, Kitti Rusznák, Gergely Szarka, et al.
Frontiers in Aging Neuroscience (2025) Vol. 17
Open Access
Genome-wide pleiotropy analysis of longitudinal blood pressure and harmonized cognitive performance measures
Moon-Il Kang, Ting Fang Alvin Ang, Sherral Devine, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Coenzyme Q10 alleviates AlCl3 and D-galactose induced Alzheimer via modulating oxidative burden and TLR-4/MAPK pathways and regulation microRNA in rat brain
Nagat F. Nawar, Doha M. Beltagy, Ehab Tousson, et al.
Toxicology Research (2025) Vol. 14, Iss. 2
Closed Access
Correlations of blood and brain NMR metabolomics with Alzheimer’s disease mouse models
Franz Knörnschild, Ella Zhang, Rajshree Ghosh Biswas, et al.
Translational Psychiatry (2025) Vol. 15, Iss. 1
Open Access
Differential involvement of neurotransmitter pathways in AD, bvFTD and MCI: Whole-brain MRI analysis
Ricardo Félix Morais, José Maria Sousa, Cemal Koba, et al.
Neurobiology of Disease (2025), pp. 106897-106897
Open Access
Therapeutic Potential of Fingolimod on Psychological Symptoms and Cognitive Function in Neuropsychiatric and Neurological Disorders
Fatemeh Rahmati‐Dehkordi, Hadi Khanifar, Nazanin Najari, et al.
Neurochemical Research (2024) Vol. 49, Iss. 10, pp. 2668-2681
Closed Access | Times Cited: 3
The potential role of gut microbiota-derived metabolites as regulators of metabolic syndrome-associated mitochondrial and endolysosomal dysfunction in Alzheimer’s disease
Young Hyun Jung, Chang Woo Chae, Ho Jae Han
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 8, pp. 1691-1702
Open Access | Times Cited: 3
Sleep as a window to understand and regulate Alzheimer’s disease: emerging roles of thalamic reticular nucleus
Haoqi Sun, Shiqian Shen, Robert J. Thomas, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 6, pp. 1711-1712
Open Access | Times Cited: 2
Gut microbiota metabolites: potential therapeutic targets for Alzheimer’s disease?
Shanshan Zhang, Jing Lu, Ziqi Jin, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Early rise of glutamate-glutamine levels in mild cognitive impairment: Evidence for emerging excitotoxicity
Laura Velu, Luc Pellerin, Adrien Julian, et al.
Journal of Neuroradiology (2023) Vol. 51, Iss. 2, pp. 168-175
Closed Access | Times Cited: 4
Synthesis of versatile neuromodulatory molecules by a gut microbial glutamate decarboxylase
Pavani Dadi, Clint W. Pauling, Abhishek Shrivastava, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Personalized, Precision Medicine to Cure Alzheimer’s Dementia: Approach #1
Jeffrey Fessel
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3909-3909
Open Access | Times Cited: 1
Cannabidiol ameliorates cognitive decline in 5×FAD mouse model of Alzheimer’s disease through potentiating the function of extrasynaptic glycine receptors
Jin Jin, Chong-Lei Fu, Jing Xia, et al.
Molecular Psychiatry (2024)
Closed Access | Times Cited: 1
Cross-species comparative hippocampal transcriptomics in Alzheimer’s disease
Marco Antônio De Bastiani, Bruna Bellaver, Giovanna Carello‐Collar, et al.
iScience (2023) Vol. 27, Iss. 1, pp. 108671-108671
Open Access | Times Cited: 3
β-amyloid’s neurotoxic mechanisms as defined by in vitro microelectrode arrays: a review
Aoife O'connell, Leo R. Quinlan, Andrea Kwakowsky
Pharmacological Research (2024) Vol. 209, pp. 107436-107436
Open Access
Page 1 - Next Page

Scroll to top